MANNKIND CORP (MNKD) Form 10-K Annual Reports
MANNKIND CORP (MNKD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MNKD
CIK: 899460
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKhurram Siddiqui
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-28 | 2026-09-25 | 4 | 0001193125-26-405736 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009820 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-391003 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001950047-26-009303 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | 8-K | 0001193125-26-361105 | View SEC Doc Filr Page |
| 424B7 | 2026-08-21 | — | 424B7 | 0001193125-26-361093 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097084 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | 4 | 0001193125-26-343016 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007817 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335054 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001503 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-23 | 8-K | 0001193125-26-316041 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308139 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308137 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308134 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308133 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308132 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308131 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 | 0001193125-26-308129 | View SEC Doc Filr Page |
| 144 | 2026-07-17 | — | 144 Filing | 0001950047-26-007191 | View SEC Doc Filr Page |
| 144 | 2026-07-17 | — | 144 Filing | 0001950047-26-007190 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-05-29 | 8-K | 0001193125-26-252544 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-27 | 8-K | 0001193125-26-243074 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-237456 | View SEC Doc Filr Page |